Protionamide molecular structure

Protionamide

Also known as: Peteha, Protomid, Trevintix, Prothionamide

CAS Number: 14222-60-7

Antitubercular (Thioamide, Second-Line)

Pharmacopeia Standards

BPEPIP

Mechanism of Action

Protionamide is the n-propyl homologue of ethionamide and follows the same activation pathway through the mycobacterial monooxygenase EthA. The activated species forms an NAD adduct that inhibits enoyl-ACP reductase InhA and halts mycolic acid biosynthesis. Its slightly greater lipophilicity is associated with improved gastrointestinal tolerability in some regimens, and it shows complete cross-resistance with ethionamide.

Technical Specifications

Generic / INN NameProtionamide
CAS Registry Number14222-60-7
Molecular FormulaC9H12N2S
Molecular Weight180.27 g/mol g/mol
Typical Purity98.0% - 102.0% (on dried basis, EP/BP assay)
Storage ConditionsStore in tightly closed, light-resistant containers below 25 degrees C in a dry, well-ventilated area; protect from light and moisture
Shelf Life48 months from date of manufacture when stored as directed
CategoryAnti-Tubercular Agents

Specifications are indicative and intended for sourcing reference only. Always confirm against the supplier's Certificate of Analysis and the applicable pharmacopeial monograph before issuing a purchase specification.

Typical Applications

Bulk API for 250 mg protionamide tablets used in longer multidrug-resistant tuberculosis regimens, and as a component of multidrug therapy for multibacillary leprosy in some national programmes.

Manufacturers (0+)

View all →
No manufacturers listed yet. Register your company to appear here.